Powered by: Motilal Oswal
30/07/2021 4:19:41 PM | Source: Angel Broking Ltd
Quote on Sun pharma by Mr. Yash Gupta, Angel Broking Ltd
News By Tags | #5948 #607 #999 #6174
Quote on Sun pharma by Mr. Yash Gupta, Angel Broking Ltd

Below is quote on Sun pharma by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd   

Sun Pharmaceuticals reported a good set of numbers for Q1FY2022, posting revenue growth of 30% at ₹9669.4 crores in Q1FY2022 which is above the market expectations. The domestic market has done well for the company in this quarter up by 38.5%. We have seen strong growth reported by all the pharma companies on the back of a recovery in the acute therapeutic segment. We expect domestic growth momentum to continue in this financial year. US formulation market reported growth of 30% which is above the market expectations. The overall company reported one of the best quarterly results in a very long time. We have a positive outlook on Sun Pharmaceuticals Ltd.

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here